| CORCEPT THERAPEUTICS INC. |
| USA |
| Gesundheit |
| US2183521028 / 529882 |
| HTD (Frankfurt) / CORT (NASDAQ) |
| FRA:HTD, ETR:HTD, HTD:GR, NASDAQ:CORT |
| - |
| https://www.corcept.com/ |
|
Corcept Therapeutics Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines that modulate cortisol activity to address serious endocrine, oncologic, metabolic, and neurologic disorders. Its commercial po..
>Volltext.. |
| 11162.29 Mio. EUR |
| 10901.09 Mio. EUR |
| 738.11 Mio. EUR |
| 7.84 Mio. EUR |
| 48.15 Mio. EUR |
| 0.46 EUR |
| 8.37 Mio. EUR |
| 98.65 Mio. EUR |
| 97.46 Mio. EUR |
| 2 |
| 19.67% |
| -57.64% |
| - |
| - |
| - |
| 3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 2.025.185 Euro. |
| CORCEPT THERAPEUTICS, CORCEPT THERAPEUTIC |
| 06.10.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|